The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Multicenter phase II study of docetaxel and oxaliplatin combination in patients with locally advanced or metastatic biliary tract cancer.
Eun-Kee Song
No relevant relationships to disclose
Hye-Suk Han
No relevant relationships to disclose
Ki Hyeong Lee
No relevant relationships to disclose
Kyu Taek Lee
No relevant relationships to disclose
Sang Byung Bae
No relevant relationships to disclose
Han Jo Kim
No relevant relationships to disclose
Samyong Kim
No relevant relationships to disclose
Hwan Jung Yun
No relevant relationships to disclose
Sang Hee Cho
No relevant relationships to disclose
Hyun-Jeong Shim
No relevant relationships to disclose
Ho-Young Yhim
No relevant relationships to disclose
Na-Ri Lee
No relevant relationships to disclose
So Yeon Jeon
No relevant relationships to disclose
Chang-Yeol Yim
No relevant relationships to disclose